✦ LIBER ✦

Serum levels of tumour necrosis factor-α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome

✍ Scribed by R. STASI; M. BRUNETTI; S. BUSSA; M. CONFORTI; L. S. MARTIN; M. LA PRESA; M. BIANCHI; A. PARMA; A. PAGANO

Book ID: 108701572
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 408 KB
Volume: 19
Category: Article
ISSN: 1751-5521
DOI: 10.1111/j.1365-2257.1997.tb00007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trilineage response to recombinant human

Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome

✍ Caroline Rey; Brigiette Bader-Meunier; Gérard Tertian; Francçise Mielot; Gil Tch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

Recombinant human granulocyte-macrophage

Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes

✍ Roberto Stasi; Adalberto Pagano; Edmondo Terzoli; Sergio Amadori 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Levamisole can reduce the high serum tum

Levamisole can reduce the high serum tumour necrosis factor-α level to a normal level in patients with erosive oral lichen planus

✍ A. Sun; J. S. Chia; J. T. Wang; C. P. Chiang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

Serum and urine levels of tumour necrosi

Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status

✍ A. Akdaş; L. Türkeri; T. Akoĝlu 📂 Article 📅 1990 🏛 Springer Netherlands 🌐 English ⚖ 284 KB

Improved multilineage response of hemato

Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

✍ A. Ganser; A. Maurer; C. Contzen; G. Seipelt; O. G. Ottmann; C. Schadeck-Gressel 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 221 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB